Costs associated with Female Urinary Incontinence: an integrative review of the literature
Author(s): Julieta Aránguiz-Ramírez, Pedro Olivares-Tirado, Xavier Castells-Oliveres
In women, the anatomical peculiarities of the pelvic floor and the risk factors for its dysfunction predispose women to suffer from Urinary Incontinence (UI), a condition that, although it does not pose a vital risk, negatively affects their quality of life and represents a high risk of the economic cost, still invisible.
To describe the scientific evidence available regarding studies of costs associated with UI in women.
Integrative review of the literature using the PubMed, Embase, ScienceDirect and Scopus databases as data sources, on studies of direct and indirect costs of UI. in women, published between 2009 and 2022. Using the search terms in Spanish and/or English: “Cost of illness”, “direct cost”, “indirect cost”, “urinary incontinence” and “woman”. The monetary values were adjusted from the date of the study to December 31,2021 and local currencies were converted to USD.
Of the 302 articles reviewed, 14 met the criteria for analysis. Some studies considered the estimate of the total economic burden including direct and indirect costs. The annual direct cost per capita ranges from US$ 153.71 to US$ 32,709 depending on the country, medication use and age, the indirect cost corresponds to an average 160 hours per year for presenteeism.
In high-income countries, the economic burden for urinary incontinence is notorious, in Latin American and Caribbean countries there are no economic evaluations regarding it, to improve the benefits for women's health, it is advisable to update.